MRI: an update and review on bio-effects and safety considerations

Amarinder Kaur; Naureen Dhillon; Simarpreet Singh; Ramandeep Singh Gambhir

doi:10.18203/2320-6012.ijrms20170620

Authors

Amarinder Kaur Department of Oral Medicine and Radiology, Gian Sagar Dental College and Hospital, Rajpura, Punjab, India
Naureen Dhillon Department of Oral Medicine and Radiology, Gian Sagar Dental College and Hospital, Rajpura, Punjab, India
Simarpreet Singh Department of Public Health Dentistry, Surendera Dental College and Research Institute, Sri Ganganagar, Rajasthan, India
Ramandeep Singh Gambhir Department of Public Health Dentistry, Rayat and Bahra Dental College and Hospital, Mohali, Punjab, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20170620

Keywords:

Diagnosis, Detection, Magnetic resonance, Treatment

Abstract

Diagnostic imaging technologies such as magnetic resonance (MR) are vital to catching signs of disease early and high quality diagnosis for treatment planning. However, some patients are unable to take advantage of its life saving capabilities. The procedures can be claustrophobic and the contraindications of MRI in patients having implants, pacemakers and also the risks associated with the use of cryogens, contrast agents etc. So this article provides an update on review on the bio effects and safety considerations for both patient and health practitioner with respect to the use of clinical MRI.

Metrics

Metrics Loading ...

References

Crooks L. Selective irradiation line scan technique for NMR imaging. IEEE Trans Nucl Sci. 1998;27:1239.

Edelstein WA, Hutchison JM, Johnson G, Redpath T. Spin warp NMR imaging and applications to human whole body imaging. Phys Med Biol. 1980;25:751-6.

Lerski RA. Physical principles of nuclear magnetic resonance imaging. Radiography. 1983;49:85-90.

Adzamli IK, Jolesz FA, Blau M. An assessment of blood-brain barrier integrity under MRI conditions: brain uptake of radiolabeled Gd-DTPA and In-DPTA-IgG. Nucl Med. 1989;30:839.

Barber BJ, Schaefer DJ, Gordon CJ, Zawieja DC, Hecker J. Thermal effects of MR imaging: worst-case studies on sheep. AJR Am J Roentgenol. 1990;155:1105-10.

Kanal E, Shellock FG, Talagala L. Safety considerations in MR imaging. Radiology. 1990;176:593-606.

Shellock FG, Woods TO, Crues JV 3rd. MR labelling information for implants and devices: explanation of terminology. Radiology. 2009;253:26-30.

Shinbane JS, Colletti PM, Shellock FG. Magnetic resonance imaging in patients with cardiac pacemakers: era of "MR Conditional" designs. J Cardiovasc Magn Reson. 2011;13:63.

Lowe MD, Plummer CJ, Manisty CH, Linker NJ. Safe use of MRI in people with Cardiac Implantable Electronic devices. Heart. 2015;101:1950-3.

Shellock FG. Biological effects and safety aspects of magnetic resonance imaging. Magn Reson Q. 1989;5:243-61.

Ahmed S, Shellock FG. Magnetic resonance imaging safety: implications for cardiovascular patients. J Cardiovasc Magn Reson. 2001;3:171-82.

Holscher HC, Bloem JL, Vanel D, Hermans J, Nooy MA, Taminiau AH et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology. 1992;182:839-44.

Shellock FG, Schaefer DJ, Grundfest W, Crues JV. Thermal effects of high-field (1.5 tesla) magnetic resonance imaging of the spine. Clinical experience above a specific absorption rate of 0.4 W/kg. Acta Radiol Suppl. 1986;369:514-6.

Stuart Crozier, Trakic A, Wang H, Liu F. Numerical study of currents in workers induced by body-motion around high-ultrahigh field MRI magnets. J Magn Reson Imaging. 2007;26:1261-77.

Boecker H, Drzezga A. A perspective on the future role of brain pet imaging in exercise science. Neuroimage. 2016;131:73-80.

Budinger TF. Nuclear magnetic resonance (NMR) in vivo studies: known thresholds for health effects. J Comput Assist Tomogr. 1981;5:800-11.

Doherty JU, Whitman GJ, Robinson MD, Harken AH, Simson MB, Spear JF et al. Changes in cardiac excitability and vulnerability in NMR fields. Invest Radiol. 1985;20:129-35.

Gulch RW, Lutz O. Influence of strong static magnetic fields on heart muscle contraction. Phys Med Biol. 1986;31:763-9.

Price DL, De Wilde JP, Papadaki AM, Curran JS, Kitney RI. Investigation of acoustic noise on 15 MRI scanners from 0.2 T to 3 T. J Magn Reson Imaging. 2001;13:288-93.

Brummett RE, Talbot JM, Charuhas P. Potential hearing loss resulting from MR imaging. Radiology. 1988;169:539-40.

Shellock FG, Kanal E. Policies, guidelines, and recommendations for MR imaging safety and patient management. SMRI Safety Committee. J Magn Reson Imaging. 1991;1:97-101.

Mosier KM. Magnetic resonance imaging of the maxilla and mandible: signal characteristics and features in the differential diagnosis of common lesions. Top Magn Reson Imaging. 2015;24:23-37.

Meyers SP, Hirsch WL Jr, Curtin HD, Barnes L, Sekhar LN, Sen C. Chondrosarcomas of the skull base: MR imaging features. Radiology. 1992;184:103-8.

Maleux G, Demaerel P, Vanslambrouck K, Aerts P, Brijs S, Tanghe W. Chondrosarcoma of the skull base: CT, MR and pathological features. Rofo. 1996;165:599-601.

Shellock FG, Parker JR, Venetianer C, Pirovano G, Spinazzi A. Safety of gadobenate dimeglumine (MultiHance): Summary of findings from clinical studies and postmarketing surveillance. Invest Radiol. 2006;41:500-9.

Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology. 2007;242:647-9.

Salivary gland pathology. In Neville BW: Oral and Maxillofacial pathology, 1995 WB Saunders.

Gingel JC, Levy BA, DePaola LG. Median palatine cyst. J Oral Maxillofac Surg. 1985;43:47-51.

Wysocki GP, Goldblatt LI. The so-called "globulomaxillary cyst" is extinct. Oral Surg Oral Med Oral Pathol. 1993;76:185-6.

Kanal E, Broome DR, Martin DR, Thomsen HS. Response to the FDA's May 23, 2007, nephrogenic systemic fibrosis update. Radiology. 2008;246:11-4.

Wolff S, Crooks LE, Brown P, Howard R, Painter RB. Tests for DNA and chromosomal damage induced by nuclear magnetic resonance imaging. Radiology. 1980;136:707-10.

De Wilde JP, Rivers AW, Price DL. A review of the current use of magnetic resonance imaging in pregnancy and safety implications for the fetus. Prog Biophys Mol Biol. 2005;87:335-53.

Tee LM, Kan EY, Cheung JC , Leung WC. Magnetic resonance imaging of the fetal brain. Hong Kong Med J. 2016;22:270-8.

International Commission on Non-Ionizing Radiation Protection. Medical magnetic resonance (MR) procedures: protection of patients. Health Phys. 2004;87:197-216.

Alorainy IA, Albadr FB, Abujamea AH. Attitude towards MRI safety during pregnancy. Ann Saudi Med. 2006;26:306-9.

Granet RB, Gelber LJ. Claustrophobia during MR imaging. N J Med. 1990;87:479-82.

Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Felmlee JP et al. American College of Radiology White Paper on MR Safety. AJR Am J Roentgenol. 2002;178:1335-47.

Kanal E, Borgstede JP, Barkovich AJ, Bell C, Bradley WG, Etheridge S et al. American College of Radiology White Paper on MR Safety: 2004 update and revisions. AJR Am J Roentgenol. 2004;182:1111-4.

Van Moore A Jr. Commentary on "ACR guidance document for safe MR practices: 2007". AJR Am J Roentgenol. 2007;188:1446.

Shellock FG. Magnetic resonance safety update 2002: implants and devices. J Magn Reson Imaging. 2002;16:485-96.